Trastuzumab Deruxtecan Has Clinically Meaningful Activity in

Fam-trastuzumab deruxtecan-nxki elicited responses that proved to be durable in patients with a range of solid tumors harboring HER2 mutations.

Related Keywords

Memorial Sloan Kettering Cancer Center , New York , United States , China , Bobt Li , , Bobst International Center , Thoracic Liquid Biopsy Program , Esmo Congress , News , Conference ,